Allergic Contact Dermatitis: Immunopathology and Potential Therapeutic Strategies
Journal of Clinical Medicine · 11.10.2025 · 14 (20) · 7175
DOI: 10.3390/jcm14207175 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 11.10.2025. Verfasst von Anders Boutrup Funch und 2 weiteren Autor:innen. Beteiligte Einrichtung: LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, 2200 Copenhagen, Denmark. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 148 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Carlsberg Foundation, LEO Foundation, Independent Research Fund Denmark.
Abstract (Originalsprache)
Allergic contact dermatitis (ACD) is a common inflammatory skin disease induced by exposure of the skin to contact allergens. Classically, ACD is defined as a delayed-type (type IV) hypersensitivity reaction mediated by allergen-specific T cells, with symptoms peaking 48–72 h after exposure to the contact allergen. This delayed response to the contact allergen is seen during patch testing, where allergen-naïve, unaffected skin of allergic individuals is exposed to the contact allergen. However, in daily life and in certain occupational settings, allergic individuals often experience rapid flare-ups/exacerbations with intensely itching erythema, oedema, and often vesicles within hours after re-exposure to the specific contact allergen. These rapid flare-ups only develop at skin sites previously exposed to the contact allergen. Thus, it is important to distinguish between the rapid-onset reaction typically experienced by the allergic individual and the delayed-type reaction typically seen after patch testing. This review summarizes current insights into the immunopathology of rapid- versus delayed-type ACD reactions and outlines potential therapeutic opportunities, as well as their current limitations, against rapid-onset ACD, including modulation of cytokine signaling, T cell survival, checkpoint pathways, and redox balance.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, 2200 Copenhagen, Denmark.
- Swiss Institute of Allergy and Asthma Research, University of Zurich, 7260 Davos, Switzerland.
ORCID-Profile: Anders Boutrup Funch, Carsten Geisler
Förderung
- Carlsberg Foundation
- LEO Foundation
- Independent Research Fund Denmark
Zitieren
APA
Funch, A. B., Geisler, C., & Bonefeld, C. M. (2025). Allergic Contact Dermatitis: Immunopathology and Potential Therapeutic Strategies. Journal of Clinical Medicine, 14(20), 7175. https://doi.org/10.3390/jcm14207175
Vancouver
Funch AB, Geisler C, Bonefeld CM. Allergic Contact Dermatitis: Immunopathology and Potential Therapeutic Strategies. Journal of Clinical Medicine. 2025;14(20):7175. doi:10.3390/jcm14207175
BibTeX
@article{Funch2025,
author = {Funch, Anders Boutrup and Geisler, Carsten and Bonefeld, Charlotte Menné},
title = {Allergic Contact Dermatitis: Immunopathology and Potential Therapeutic Strategies},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {20},
pages = {7175},
doi = {10.3390/jcm14207175}
}
EUVIMED